Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Sangamo Biosciences (GB:0R1D)
LSE:0R1D
RESEARCH TOOLSreports
Sangamo Biosciences (0R1D) Share Price & Analysis
0 Followers
0R1D Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.29 - $1.67
Previous Close$0.53
Volume17.44K
Average Volume (3M)46.96K
Market Cap
$104.87M
Enterprise Value$57.38M
Total Cash (Recent Filing)$81.00M
Total Debt (Recent Filing)$33.52M
Price to Earnings (P/E)N/A
Beta2.42
Next Earnings
Aug 07, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding178,906,350
10 Day Avg. Volume999
30 Day Avg. Volume46,960
Standard Deviation0.22
R-Squared0.02
Alpha0.01
Financial Highlights & Ratios
Price to Book (P/B)1.11
Price to Sales (P/S)13.98
Price to Cash Flow (P/CF)-0.50
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.33
Enterprise Value/Gross Profit0.33
Enterprise Value/Ebitda-0.24
Forecast
1Y Price Target
$2.60Price Target Upside374.45% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering7
Sangamo Biosciences News
Options Prices
Currently, No data available
---
Ownership Overview
0.00% Insiders
0.00% Mutual Funds
10.02% Other Institutional Investors
89.98% Public Companies and
Individual Investors
0R1D FAQ
What was Sangamo Biosciences’s price range in the past 12 months?
Sangamo Biosciences lowest share price was $0.29 and its highest was $1.67 in the past 12 months.
What is Sangamo Biosciences’s market cap?
Currently, no data Available
When is Sangamo Biosciences’s upcoming earnings report date?
Sangamo Biosciences’s upcoming earnings report date is Aug 07, 2024 which is in 96 days.
How were Sangamo Biosciences’s earnings last quarter?
Currently, no data Available
Is Sangamo Biosciences overvalued?
According to Wall Street analysts Sangamo Biosciences’s price is currently Undervalued.
Does Sangamo Biosciences pay dividends?
Sangamo Biosciences does not currently pay dividends.
What is Sangamo Biosciences’s EPS estimate?
Sangamo Biosciences’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Sangamo Biosciences have?
Currently, no data Available
What happened to Sangamo Biosciences’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Sangamo Biosciences?
Among the largest hedge funds holding Sangamo Biosciences’s share is Wexford Capital LP. It holds Sangamo Biosciences’s shares valued at 25K.
---
Sangamo Biosciences Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$2.60 (374.45% Upside)
$2.60 (374.45% Upside)
Blogger Sentiment
Bullish
GB:0R1D Sentiment 100%
Sector Average 70%
Sector Average 70%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-65.03%
12-Months-Change
Fundamentals
Return on Equity
-136.47%
Trailing 12-Months
Asset Growth
-70.61%
Trailing 12-Months
Company Description
Sangamo Biosciences
Sangamo Therapeutics, Inc. engages in researching and developing transcription factors in the regulation of genes. It focuses on the research, development and commercialization of engineered DNA-binding proteins for therapeutic genome editing and gene regulation technology platform is enabled by the engineering of a class of transcription factors known as zinc finger DNA-binding proteins. The company was founded by Edward O. Lanphier II in 1995 and is headquartered in Richmond, CA.
---
0R1D Company Deck
---
0R1D Earnings Call
Q4 2024
0:00 / 0:00
---
0R1D Stock 12 Months Forecast
Average Price Target
$2.60
▲(374.45% Upside)
Technical Analysis
Sangamo Biosciences
―
Crispr Therapeutics AG
―
Curis
―
Intellia Therapeutics
―
RegenXBio
―
---